Fluconazole prophylaxis against fungal colonization and infection in preterm infants.
Open accessThe DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Invasive fungal infection is associated with substantial morbidity and mortality in preterm infants. We evaluated the efficacy of prophylactic fluconazole in preventing fungal colonization and invasive infection in extremely-low-birth-weight infants. METHODS: We conducted a prospective, randomized, double-blind clinical trial over a 30-month period in 100 preterm infants with birth weights of less than 1000 g. The infants were randomly assigned during the first five days of life to receive either intravenous fluconazole or placebo for six weeks. We obtained weekly surveillance cultures from all patients. RESULTS: The 50 infants randomly assigned to fluconazole and the 50 control infants were similar in terms of birth weight, gestational age at birth, and base-line risk factors for fungal infection. During the six-week treatment period, fungal colonization was documented in 30 infants in the placebo group (60 percent) and 11 infants in the fluconazole group (22 percent; difference in risk, 0.38; 95 percent confidence interval, 0.18 to 0.56; P=0.002). Invasive fungal infection with positive growth of fungal isolates from the blood, urine, or cerebrospinal fluid developed in 10 infants in the placebo group (20 percent) and none of the infants in the fluconazole group (difference in risk, 0.20; 95 percent confidence interval, 0.04 to 0.36; P=0.008). The sensitivities of the fungal isolates to fluconazole did not change during the study, and no adverse effects of the fluconazole therapy were documented. CONCLUSIONS: Prophylactic administration of fluconazole during the first six weeks of life is effective in preventing fungal colonization and invasive fungal infection in infants with birth weights of less than 1000 g.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, antifungal prophylaxis is now routinely used for extremely premature newborns in some neonatal units and for patients with certain types of hematologic malignancies, dramatically reducing rates of candidemia in these populations (15,16).”
From Population-Based Active Surveillance for Culture-Confirmed Candidemia — Four Sites, United States, 2012–2016 (2019) · cites this paper as [16]
In the citing paper
“The high incidence of candidemia among infants, as well as the significant difference by race in this age group, was noted in the study of Kao et al. (16) and is known to be an important public health problem in this population (17, 35, 42).”
In the citing paper
“reduced the rate of invasive can-didiasis from 20% to 0% ( ) [344].”
From Guidelines for Treatment of Candidiasis (2004) · cites this paper as [344]
In the citing paper
“Regarding the latter observation, it is noteworthy that the formation of biofilms on central venous catheters by Candida spp. is associated with nosocomial infections (121, 122).”
From Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem (2007) · cites this paper as [121]
In the citing paper
“C. parapsilosis is notorious for the ability to form biofilms on catheters and other implanted devices (26, 38, 56, 80, 121, 122, 129, 269), for nosocomial spread by hand carriage, and for persistence in the hospital environment (38, 80, 122, 129, 262).”
From Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem (2007) · cites this paper as [121]
Citations
Cites
(2001) · Statistics for Psychologists · doi:10.4324/9781410605542-11 · Cited by 6,877
Hennekens, C. H., Buring, J. E., & Mayrent, S. L. (1987) · Medical Entomology and Zoology · Cited by 2,319
Manual of Clinical Microbiology, 7th ed.
Balows, A. (2000) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(99)00102-9 · Cited by 1,613
Assessing symptom distress in cancer patients: The M. D. Anderson Symptom Inventory
Cleeland, C. S., Mendoza, T. R., Wang, X. S., Chou, C., Harle, M. T., Morrissey, M., & Engstrom, M. C. (2000) · Cancer · doi:10.1002/1097-0142(20001001)89:7<1634::aid-cncr29>3.0.co;2-v · Cited by 1,360
Goodman, J. L., Winston, D. J., Greenfield, R. A., Chandrasekar, P. H., Fox, B., Kaizer, H., Shadduck, R. K., Shea, T. C., Stiff, P., Friedman, D. J., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199203263261301 · Cited by 1,174
Reference method for broth dilution antifungal susceptibility testing of yeasts : Approved standard
Rex, J. H., & Clinical (2008) · Clinical and Laboratory Standards Institute eBooks · Cited by 1,052
Manual of clinical microbiology
Murray, P. R., Versalovic, J. A., & Jorgensen, J. H. (1999) · Cited by 880
Resistance of Candida species to fluconazole
Rex, J. H., Rinaldi, M. G., & Pfaller, M. A. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.1.1 · Cited by 877
Stoll, B. J., Gordon, T., Korones, S. B., Shankaran, S., Tyson, J. E., Bauer, C. R., Fanaroff, A. A., Lemons, J. A., Donovan, E. F., Oh, W., et al. (1996) · The Journal of Pediatrics · doi:10.1016/s0022-3476(96)70191-9 · Cited by 873
Slavin, M. A., Osborne, B., Adams, R., Levenstein, M. J., Schoch, H. G., Feldman, A. R., Meyers, J. D., & Bowden, R. A. (1995) · Journal of Infectious Diseases · doi:10.1093/infdis/171.6.1545 · Cited by 820
Research works printed but not linked: 2
- Spicer AD, 1992, Med Microbiol Lett, 1, 284
- 10.1111/j.1574-6968.2000.tb08938.x · doi:10.1111/j.1574-6968.2000.tb08938.x · Paper page
Cited by
Items 301–400 of 518
Health Care-Associated Infections
Srinivasan, L., & Evans, J. R. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-40139-5.00040-1 · Cited by 11
Candida colonization in the nursery
Manzoni, P., Mostert, M., Jacqz-Aigrain, É., Stronati, M., & Farina, D. (2012) · Jornal de Pediatria · doi:10.2223/jped.2201 · Cited by 11
Moran, C., Smith, P. B., Cohen‐Wolkowiez, M., & Benjamin, D. K. (2009) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.175 · Cited by 10
Xia, B., Tang, J., Xiong, Y., Li, X., & Mu, D. (2010) · World Journal of Pediatrics · doi:10.1007/s12519-010-0030-5 · Cited by 11
Single-center trials in neonatology: Issues to consider
Sinha, I. P., & Sinha, S. K. (2015) · Seminars in Fetal and Neonatal Medicine · doi:10.1016/j.siny.2015.08.003 · Cited by 11
Colonisation à levures chez les prématurés de moins de 1500g hospitalisés en réanimation néonatale
Benjamin, M. D., Jolivet, E., Desbois, N., Pignol, J., Ketterer, S., Pierre-Louis, L., & Fléchelles, O. (2016) · Archives de Pédiatrie · doi:10.1016/j.arcped.2016.05.018 · Cited by 10
Kim, Y. K., Lee, J. Y., Oh, J., Rhee, S., Shin, S. H., Yoon, S. H., Lee, S., Kim, H., & Yu, K. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01960-18 · Cited by 11
“weight (ELBW) via the suppression of Candida colonization (6, 9, 11, 14, 15).”
BackgroundAlFaleh, K. M. (2012) · Journal of Clinical Neonatology · doi:10.4103/2249-4847.96745 · Cited by 10
“According to this data, Lactoferrin has the same impact of prevention IFI as compared to fluconazole.[2,3] Although the death rate in Lactoferrin group was one-third of the control one, this did not reach statistical significance mostly due to lack of power.”
BackgroundNeonatal candidiasis: prophylaxis and treatment
Tiffany, K. F., Smith, P. B., & Benjamin, D. K. (2005) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.6.10.1647 · Cited by 11
“Randomised, controlled trials of prophylaxis in neonates [69-71,82,83].”
BackgroundMethodBernardini, L. B., Healy, H. M., Battarbee, A. N., Brennick, E., Church, P., Pavlek, L. R., Tagliaferro, T., Travers, C. P., Vier, K., Walsh, J., et al. (2025) · Journal of Perinatology · doi:10.1038/s41372-025-02252-x · Cited by 9
Wilson, A. P., Bogie, B., Chaaban, H., & Burge, K. Y. (2023) · Microorganisms · doi:10.3390/microorganisms11040909 · Cited by 10
“Prophylactic antifungals, including nystatin and fluconazole, are frequently used in the NICU in an attempt to reduce the high rates of invasive candidiasis among preterm, extremely low birthweight (ELBW) infants [75,116,128,129].”
BackgroundResistance to Antifungal Agents
Arthington, B. A., & Rex, J. H. (2007) · Springer eBooks · doi:10.1007/978-0-387-72418-8_10 · Cited by 9
Candidoses invasives en réanimation néonatale
Brissaud, O., Tandonnet, O., & Guichoux, J. (2011) · Archives de Pédiatrie · doi:10.1016/s0929-693x(11)70937-x · Cited by 9
Emerging Cutaneous Infections in the Premature Neonate
Horii, K. A., & Nopper, A. J. (2007) · Advances in Dermatology · doi:10.1016/j.yadr.2007.07.012 · Cited by 9
Skin Care of Infants Born at 21–23 Weeks’ Gestation
Hobson, A. A., Davila, R. C., Goers, K., Phearman, L. A., Berrebi, K. G., & Dagle, J. M. (2024) · NeoReviews · doi:10.1542/neo.26-1-004 · Cited by 8
Neonatal Invasive Fungal Infections
Kaufman, D. A., & Mukhopadhyay, S. (2024) · Clinics in Perinatology · doi:10.1016/j.clp.2024.10.004 · Cited by 8
Self-citationNew Antifungal and Antiviral Dosing
Wade, K. C., & Monk, H. M. (2014) · Clinics in Perinatology · doi:10.1016/j.clp.2014.10.010 · Cited by 9
Xie, J., Zhu, L., Zhu, T., Jian, Y., Ding, Y., Zhou, M., & Feng, X. (2019) · Journal of Human Nutrition and Dietetics · doi:10.1111/jhn.12634 · Cited by 8
An Update on the Epidemiology of Candidemia in Children
Dutta, A., Zaoutis, T. E., & Palazzi, D. L. (2012) · Current Fungal Infection Reports · doi:10.1007/s12281-012-0113-y · Cited by 8
Recently tested strategies to reduce nosocomial infections in the neonatal intensive care unit
Toltzis, P., & Walsh, M. C. (2010) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.09.129 · Cited by 9
Neonatal Pharmacology: Rational Therapeutics for the Most Vulnerable
James, L., & Ito, S. (2009) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.212 · Cited by 8
Pammi, M., Eddama, O., & Weisman, L. E. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006068.pub2 · Cited by 11
Vohr, B. R., McGowan, E. C., Brumbaugh, J. E., & Hintz, S. R. (2021) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2021.10.015 · Cited by 7
Antibiotic Resistance in the NICU
Johnson, P. J. (2012) · Neonatal Network The Journal of Neonatal Nursing · doi:10.1891/0730-0832.31.2.109 · Cited by 7
Next Steps for Health Care-Associated Infections in the Neonatal Intensive Care Unit
Brachio, S. S., Gu, W., & Saiman, L. M. (2023) · Clinics in Perinatology · doi:10.1016/j.clp.2023.02.001 · Cited by 8
Infections fongiques invasives du grand prématuré
Hot, A., Mittaine, B., & Dupont, B. (2006) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2006.09.001 · Cited by 10
Candida Colonization Index in the Management of Critically III Patients
Eggimann, P., & Pittet, D. (2006) · Yearbook of intensive care and emergency medicine · doi:10.1007/3-540-33396-7_56 · Cited by 9
Epidemiology and Prevention of Neonatal Candidiasis: Fluconazole for All Neonates?
Kaufman, D. A. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-0981-7_9 · Cited by 8
“In infants weighing less than 1000 g, with ICI, mortality rates range from 23 to 66% of the control patients in the prophylaxis studies (Kaufman et al., 2001; Manzoni et al., 2006; Kaufman et al., 2005; Weitkamp et al., 2008; Kicklighter et al., 2001; Healy et al., 2005; Bertini et al., 2005; Manzoni et al., 2007; Uko…”
BackgroundInfluentialSelf-citationTherapeutic armamentarium against systemic fungal infections
Cisneros, J. M., & Cordero, E. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01606.x · Cited by 8
Los aspectos epidemiológicos cambiantes de la candidemia y sus implicaciones clinicoterapéuticas
Salavert, M., Ramos, I. J., & Pemán, J. (2006) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1157/13094277 · Cited by 18
A Review of Candida Prophylaxis in the Neonatal Intensive Care Population
Chicella, M. F., Woodruff, E. D., & Desai, M. M. (2011) · The Journal of Pediatric Pharmacology and Therapeutics · doi:10.5863/1551-6776-16.4.237 · Cited by 7
Prevention of catheter-related bloodstream infections in the neonatal intensive care setting
Moran‐Gilad, J., & Borer, A. (2006) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.4.5.861 · Cited by 7
de Alarcón, P. A. (2005) · Cambridge University Press eBooks · doi:10.1017/cbo9780511545306.012 · Cited by 6
Bacterial and Fungal Infections in the Neonate: Current Diagnosis and Therapy
Sánchez, P. J. (2004) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-8993-2_14 · Cited by 6
Rikken, B., Hartwig, N. G., & van den Hoek, J. (2008) · Current Urology · doi:10.1159/000115292 · Cited by 6
Fluconazole to Prevent Systemic Fungal Infections in Infants: Reviewing the Evidence
Wilkerson, J., McPherson, C. C., & Donze, A. (2010) · Neonatal Network The Journal of Neonatal Nursing · doi:10.1891/0730-0832.29.5.323 · Cited by 6
Adams-Chapman, I. S., & Stoll, B. J. (2011) · WORLD SCIENTIFIC eBooks · doi:10.1142/9789814313476_0016 · Cited by 6
Therapeutic drug monitoring for antifungal triazoles: pharmacologic background and current status
Groll, A. H., & Gastine, S. (2019) · Handbook of analytical separations · doi:10.1016/b978-0-444-64066-6.00009-5 · Cited by 8
Difficulties in the diagnosis and management of eight infants with secondary pseudohypoaldosteronism
Günay, F., Şıklar, Z., & Berberoğlu, M. (2022) · The Turkish Journal of Pediatrics · doi:10.24953/turkjped.2021.1443 · Cited by 6
Jannatdoust, A., & Imani, V. (2015) · International Journal of Women s Health and Reproduction Sciences · doi:10.15296/ijwhr.2015.44 · Cited by 7
Topical Nystatin for the Prevention of Catheter-Associated Candidiasis in ELBW Infants
Bodin, M. B., Godoy, G., & Philips, J. B. (2015) · Advances in Neonatal Care · doi:10.1097/anc.0000000000000170 · Cited by 6
Wattier, R. L., & Steinbach, W. J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-40181-4.00293-0 · Cited by 6
Healthcare-Associated Infections
Srinivasan, L. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-82823-9.00037-4 · Cited by 7
Fungal Chemoprophylaxis with Fluconazole in Preterm Infants
Sesmero, J. M. M., Sedano, F. J. F., García, T. M., Brussi, M. M., Ferrández, J. S.-R., Fernández, R. D., & Guillén, C. M. (2005) · Pharmacy World & Science · doi:10.1007/s11096-005-7909-6 · Cited by 6
Yoneda, K., Shinjo, D., Takahashi, N., & Fushimi, K. (2024) · PLoS ONE · doi:10.1371/journal.pone.0295528 · Cited by 5
Peixoto-Rodrigues, M. C., da Costa, G. L., Pinto, T. N., Adesse, D., Oliveira, M. M. E., & Hauser‐Davis, R. A. (2023) · BMC Microbiology · doi:10.1186/s12866-023-03128-w · Cited by 5
“In fact, Trichosporon spp. have already been detected on the skin of premature infants [61].”
BackgroundPark, K. H., Park, S. J., Bae, M.-H., Jeong, S.-H., Jeong, M.-H., Lee, N., Han, Y. M., & Byun, S. Y. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11010260 · Cited by 5
“In the absence of antifungal prophylaxis, up to 60% of ELBW infants become colonized in the first 2–3 weeks after birth [7].”
BackgroundWijayanto, D., Amir, I., Wahyuningsih, R., & Windiastuti, E. (2016) · Sari Pediatri · doi:10.14238/sp11.4.2009.229-37 · Cited by 6
Diagnosis, Risk Factors, Outcomes, and Evaluation of Invasive Candida Infections
Kaufman, D. A., Liken, H. B., & Odackal, N. J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-54391-0.00007-2 · Cited by 8
Self-citationNovel approaches to antifungal prophylaxis
Ostrosky-Zeichner, L. L. (2004) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.13.6.665 · Cited by 5
“[47] evaluated the efficacy of prophylactic fluconazole in preventing fungal colonisation and invasive infection in extremely low-birth-weight infants.”
BackgroundFluconazole prophylaxis in high-risk, very low birth weight infants
Kim, S. Y., Lee, S. J., Kim, M. J., Song, E. S., & Choi, Y. Y. (2007) · Korean Journal of Pediatrics · doi:10.3345/kjp.2007.50.7.636 · Cited by 5
Fluconazole Prophylaxis against Fungal Infection in Preterm Infants
Dani, C., Bertini, G., & Pezzati, M. (2002) · New England Journal of Medicine · doi:10.1056/nejm200206133462415 · Cited by 5
Aviles-Otero, N., Ransom, M. A., Weitkamp, J.-H., Charlton, J. R., Sullivan, B. A., Kaufman, D. A., & Fairchild, K. D. (2020) · Journal of Neonatal-Perinatal Medicine · doi:10.3233/npm-200513 · Cited by 4
“Some reports implicate Candida sp . as a major cause of UTI in preterm infants [18] but both UVa and VUMC routinely administer fluconazole prophylaxis [19–21]andtherewereonlytwoUTIscausedby Candida in patients who were not receiving fluconazole prophylaxis.”
Self-citationManagement of invasive fungal infections in the pediatric intensive care unit
Fisher, B. T., Zaoutis, T. E., & Chiotos, K. (2015) · Journal of Pediatric Intensive Care · doi:10.3233/pic-14108 · Cited by 4
“If such a prediction model could be developed, targeted prophylaxis, as is done with HSCT patients, patients with high risk leukemias, and sometimes extremely low birth weight infants could be initiated in a subset of high risk PICU patients (Table 2) [49, 64–71].”
MethodGiant Mycotic Right Atrial Thrombus Due to Candida dubliniensis Septicemia in a Premature Infant
Grizelj, R., Vuković, J., Šarić, D., & Luetić, T. (2010) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3181e0ccc0 · Cited by 4
Current Epidemiology and Management of Invasive Candidiasis in Infants
Zimmerman, K. O., & Smith, P. B. (2014) · Current Fungal Infection Reports · doi:10.1007/s12281-013-0167-5 · Cited by 4
“fluconazole[82] placebo 100 <1,000 g 20 0.”
Bendel, C. M. (2006) · Elsevier eBooks · doi:10.1016/b0-72-160537-0/50035-9 · Cited by 4
Effect of Fluconazole Prophylaxis to Control Candida Infection in High-Risk Preterm Infants
Kim, C. S., Hong, S. A., Lee, S. L., & Kim, H. S. (2010) · KUMeL Repository (Keimyung University) · Cited by 4
Neonatal Bacterial and Fungal Infections
Stronati, M., & Borghesi, A. (2012) · Springer eBooks · doi:10.1007/978-88-470-1405-3_116 · Cited by 4
Nuove strategie di prevenzione delle infezioni nel neonato pretermine
Manzoni, P., Decembrino, L., Gallo, E., Rizzollo, S., Franco, C., Mostert, M., Stronati, M., & Farina, D. (2010) · Recenti Progressi in Medicina · doi:10.1701/534.6395 · Cited by 5
Fosfluconazole for Antifungal Prophylaxis in Very Low Birth Weight Infants
Takahashi, D., Nakamura, T., Shigematsu, R., Matsui, M., Araki, S., Kubo, K., Sato, H., & Shirahata, A. (2009) · International Journal of Pediatrics · doi:10.1155/2009/274768 · Cited by 4
“Mild and transient increases of liver enzymes, without clinical implications, have previously been described in infants receiving fluconazole [3, 4], and therefore a transient increase in the hepatic aminotransferase levels may occur similarly when using fosfluconazole in VLBW infants.”
BackgroundCo-infection with bacterial and fungal endocarditis in neonate and successful medical treatment
Tahazzul, M., Singh, S., Sharma, A., & Khan, M. W. (2013) · Clinical Epidemiology and Global Health · doi:10.1016/j.cegh.2012.12.002 · Cited by 4
Mucocutaneous and Deeply Invasive Candidiasis
Shoham, S., Nucci, M., & Walsh, T. J. (2011) · Elsevier eBooks · doi:10.1016/b978-0-7020-3935-5.00088-4 · Cited by 4
Kulkarni, V., Bhadade, A. A., & Putta, S. D. (2017) · Annals of Pathology and Laboratory Medicine · doi:10.21276/apalm.2017.1000 · Cited by 4
“[18] These results have led to wide adoption of targeted fluconazole prophylaxis strategy in neonatal intensive care units for VLBW infants to prevent invasive candidiasis.”
BackgroundLiu, J., & Shortliffe, L. M. D. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-2702-9.00049-0 · Cited by 4
Levy, O. (2004) · Pediatric Research · doi:10.1203/01.pdr.0000112161.48023.86 · Cited by 4
Steinbach, W. J., & Dvorak, C. C. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-2702-9.00295-6 · Cited by 5
Aspects of neonatal septicaemia : prevention and complications
Hjalmarsson, L. B. (2018) · Cited by 3
Clinical pharmacology of antiinfective drugs
Wade, K. C., & Benjamin, D. K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-79525-8.00049-4 · Cited by 4
Costa, S., Barone, G., Vento, G., Tirone, C., Perelli, S., & Romagnoli, C. (2014) · Acta Paediatrica · doi:10.1111/apa.12613 · Cited by 3
“Prophylaxis started within the first 24 h of life, and fluconazole was administered intravenously at a dose of 3 mg/kg every third day for 6 weeks or until a central vascular access was necessary (5).”
BackgroundT Cell Depleted Haploidentical Transplantation: Positive Selection
Aversa, F. (2011) · Pediatric Reports · doi:10.4081/pr.2011.s2.e14 · Cited by 3
Care of the Extremely Low-Birth-Weight Infant
Eichenwald, E. C. (2005) · Elsevier eBooks · doi:10.1016/b978-072169347-7.50034-2 · Cited by 3
Panackal, A. A. (2013) · Journal of Mycology · doi:10.1155/2013/413874 · Cited by 3
Efficacy and safety of antifungals in pediatric patients
Groll, A. H. (2011) · Early Human Development · doi:10.1016/j.earlhumdev.2011.01.016 · Cited by 7
Fungal Prophylaxis in the Neonatal Intensive Care Unit
Healy, C. M. (2008) · NeoReviews · doi:10.1542/neo.9-12-e562 · Cited by 3
Antimicrobial Management of Neonatal Sepsis
Kim, E. A. (2012) · Journal of the Korean Society of Neonatology · doi:10.5385/jksn.2012.19.2.53 · Cited by 3
Prevention of InvasiveCandidaInfections in the Neonatal Intensive Care Unit
Kim, C. S. (2011) · Korean Journal of Pediatric Infectious Diseases · doi:10.14776/kjpid.2011.18.1.15 · Cited by 3
Urinary Tract Infections, Renal Abscess, and Other Complex Renal Infections
Davenport, M. T., & Shortliffe, L. M. D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-40181-4.00048-7 · Cited by 3
Current Trends in Epidemiology and Antimicrobial Resistance in Neonatal Sepsis
Chávez‐Bueno, S., & McCulloh, R. J. (2018) · Annual update in intensive care and emergency medicine · doi:10.1007/978-3-319-73670-9_4 · Cited by 7
Bendel, C. M. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-6400-8.00033-x · Cited by 3
HEALTH CARE–ASSOCIATED INFECTIONS
Huskins, W. C., & Goldmann, D. A. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-4044-6.50249-1 · Cited by 3
Antifungal Agents: Resistance and Rational Use
Odds, F. C. (2005) · Springer eBooks · doi:10.1007/0-387-22852-7_17 · Cited by 4
Neonatal Meningitis: Current Treatment Options
Kaufman, D. A., Zanelli, S. A., & Sánchez, P. J. (2008) · Elsevier eBooks · doi:10.1016/b978-1-4160-3157-4.10012-4 · Cited by 3
Self-citationVendettuoli, V., Vento, G., Tirone, C., Posteraro, B., & Romagnoli, C. (2009) · PEDIATRICS · doi:10.1542/peds.2008-3008 · Cited by 3
Maslamani, A., Almutairi, M., Zaila, S. S., Alonazey, S. I., Albogami, A. M., Alrashedi, A. N., Almotiab, M. A. R., Alanazi, S. Q. S., Albariqi, B. A. M., Albogami, H. M., et al. (2024) · Journal of Ecohumanism · doi:10.62754/joe.v3i8.6661 · Cited by 2
Candidémie et candidose généralisée
Eggimann, P., & Pittet, D. (2010) · EMC-Anesthésie réanimation/Encyclopédie médico-chirurgicale. Anesthésie, réanimation · doi:10.1016/s0246-0289(10)50741-2 · Cited by 3
Patel, R. M. (2017) · Acta Paediatrica · doi:10.1111/apa.13719 · Cited by 2
“to reduce the incidence of invasive candidiasis (3,4), particularly among preterm infants weighing <1000 g at birth (5).”
BackgroundJaoude, R. A., Zauk, A., Morel, C., McClure, D., Lamacchia, M., & DeBari, V. A. (2014) · Medical Microbiology and Immunology · doi:10.1007/s00430-014-0337-2 · Cited by 2
Antibiotic Considerations for Necrotizing Enterocolitis
Rochon, M.-E., Moussa, A., & Autmizguine, J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-54391-0.00013-8 · Cited by 2
Albakri, A. (2019) · Research and Review Insights · doi:10.15761/rri.1000151 · Cited by 3
Sanami, M. N., Radfar, M., Shirvani, F., Nabavi, M., & Gachkar, L. (2015) · Archives of Pediatric Infectious Diseases · doi:10.5812/pedinfect.21234 · Cited by 2
“2015;3(4):e21234 and birth weight are related to a decrease in the risk of developing a candidiasis infection.”
BackgroundFungal sepsis in a Level III Neonatal Intensive Care Unit: a 10-year retrospective analysis
Silva, R., Grilo, M., Pissarra, S., & Guimarães, H. (2014) · Journal of pediatric and neonatal individualized medicine · doi:10.7363/231 · Cited by 2
“Systemic fluconazole prophylaxis is not performed in every VLBW or ELBW newborns, as it is suggested by some authors [17, 18] because our NICU does not qualify as a high prevalence unit, and there are not enough data to support that practice as it is shown in a 2013 Cochrane review [19] and in more recent data [20].”
BackgroundHealthcare-Associated Infections in Pediatrics
Sarvikivi, E. (2008) · STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) · Cited by 4
Rational Approach to Pediatric Antifungal Therapy
Steinbach, W. J. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-7185-2_16 · Cited by 2
“In a prospective, randomized double-blind trial over a 30-month period of 100 infants with birthweights less than 1,000 g, those infants who received fluconazole for 6 weeks had a decrease in fungal colonization (22 vs. 60%) as well as a decrease in the development of invasive fungal infection compared to placebo (0 v…”
BackgroundComplicações da candidíase sistêmica em UTI neonatal
Pedroso, C. P. A., & Krebs, V. L. J. (2008) · Revista de Ciências Médicas e Biológicas · doi:10.9771/cmbio.v7i3.4472 · Cited by 2
Manzoni, P., Farina, D., Leonessa, M., Priolo, C., & Gomirato, G. (2006) · Critical Care · doi:10.1186/cc3958 · Cited by 2
“In addition to the high-risk surgical patients considered by Ho and coworkers [1], preterm neonates in the neonatal intensive care unit are at increased risk for fungal colonization and infection but – despite positive reports from a limited number of institutions including ours [2-4] – the use of prophylactic flucona…”
BackgroundAntifungal Therapy in Pediatric Patients
Lehrnbecher, T., Bochennek, K., Schrey, D., & Groll, A. H. (2011) · Current Fungal Infection Reports · doi:10.1007/s12281-011-0046-x · Cited by 2
“Because fluconazole has been shown to reduce Candida infections in low-birth-weight infants [ 22 , 23], it is a preventive option for centers with a high frequency (>10%) of invasive Candida infections.”
BackgroundRecent Studies on Invasive Fungal Diseases in Children and Adolescents: an Update
Nieves, D. J., & Arrieta, A. C. (2014) · Current Fungal Infection Reports · doi:10.1007/s12281-013-0172-8 · Cited by 2
Prevention of Fungal Infection in Neonatal Intensive Care Unit
Choi, Y. Y. (2013) · Neonatal Medicine · doi:10.5385/nm.2013.20.3.361 · Cited by 2
Cetin, M., Ozen, S., Yıldırımer, M., Devecí, M., Coşkun, Ş., & Kızılkaya, M. H. (2013) · Case Reports in Clinical Medicine · doi:10.4236/crcm.2013.25084 · Cited by 3
“Frequency of invasive fungal infection in newborns is increasing due to the reasons such as increasing number of low/extremely low birth weight newborns that are hospitalized in newborn intensive care units, increased invasive interventions, need for parenteral nutrition, use of broad-spectrum antibiotics and need for…”
Background
Metadata
- Authors
- Kaufman, D., Boyle, R., Hazen, K. C., Patrie, J. T., Robinson, M., & Donowitz, L. G.
- Affiliations
- University of Virginia (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2001-12-06
- Volume
- 345
- Issue
- 23
- Pages
- 1660-1666
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2016673581
- Cited by
- 523
- References
- 46
- Citations by year
- 2026: 3 · 2025: 10 · 2024: 13 · 2023: 9 · 2022: 10 · 2021: 8 · 2020: 8 · 2019: 21 · 2018: 17 · 2017: 18 · 2016: 19 · 2015: 18 · 2014: 24 · 2013: 26 · 2012: 42
- FWCI
- 12.45
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Neonatal and Maternal Infections
- Health Sciences › Medicine › Ophthalmology › Ocular Infections and Treatments
- Keywords
- fluconazole, antifungal prophylaxis, preterm infants, extremely low birth weight infants, invasive fungal infections, fungal colonization
- MeSH terms
- Antifungal Agents, Bacterial Infections, Candida, Candida albicans, Candidiasis, Double-Blind Method, Humans, Infant, Newborn, Infant, Premature, Infant, Premature, Diseases, Infusions, Intravenous, Microbial Sensitivity Tests, Mycoses, Prospective Studies, Trichosporon, Colony Count, Microbial, Fluconazole, Infant, Very Low Birth Weight
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.